Applied DNA Sciences Inc (APDN)
0.3067
-0.02
(-7.06%)
USD |
NASDAQ |
Apr 23, 12:05
Applied DNA Sciences Cash from Operations (TTM): -7.592M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -7.592M |
| September 30, 2023 | -6.218M |
| June 30, 2023 | -6.796M |
| March 31, 2023 | -7.182M |
| December 31, 2022 | -7.658M |
| September 30, 2022 | -8.977M |
| June 30, 2022 | -10.43M |
| March 31, 2022 | -9.926M |
| December 31, 2021 | -12.93M |
| September 30, 2021 | -13.39M |
| June 30, 2021 | -11.66M |
| March 31, 2021 | -13.42M |
| December 31, 2020 | -12.57M |
| September 30, 2020 | -11.14M |
| June 30, 2020 | -9.937M |
| March 31, 2020 | -8.211M |
| December 31, 2019 | -8.079M |
| September 30, 2019 | -6.862M |
| June 30, 2019 | -7.594M |
| March 31, 2019 | -7.440M |
| December 31, 2018 | -5.858M |
| September 30, 2018 | -6.917M |
| June 30, 2018 | -5.322M |
| March 31, 2018 | -6.060M |
| December 31, 2017 | -7.983M |
| Date | Value |
|---|---|
| September 30, 2017 | -7.479M |
| June 30, 2017 | -9.012M |
| March 31, 2017 | -9.372M |
| December 31, 2016 | -9.245M |
| September 30, 2016 | -9.897M |
| June 30, 2016 | -9.189M |
| March 31, 2016 | -8.218M |
| December 31, 2015 | -7.331M |
| September 30, 2015 | -6.966M |
| June 30, 2015 | -7.468M |
| March 31, 2015 | -8.222M |
| December 31, 2014 | -8.802M |
| September 30, 2014 | -8.513M |
| June 30, 2014 | -8.444M |
| March 31, 2014 | -8.244M |
| December 31, 2013 | -8.196M |
| September 30, 2013 | -7.870M |
| June 30, 2013 | -6.690M |
| March 31, 2013 | -6.006M |
| December 31, 2012 | -4.890M |
| September 30, 2012 | -3.961M |
| June 30, 2012 | -4.529M |
| March 31, 2012 | -4.115M |
| December 31, 2011 | -4.103M |
| September 30, 2011 | -3.762M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-13.42M
Minimum
Mar 2021
-6.218M
Maximum
Sep 2023
-9.504M
Average
-8.977M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
| Fonar Corp | 15.29M |
| XWELL Inc | -16.07M |
| ProPhase Labs Inc | -11.35M |
| Veracyte Inc | 44.22M |
| OncoCyte Corp | -23.32M |